Evidence map›Paper›PMID 36185679›Full record

ReviewFrontiers in nutrition2022

Camel milk protectiveness toward multiple liver disorders: A review.

Khunsha Shakeel, Roshina Rabail, Iahtisham-Ul-Haq, Sabrina Sehar, Asad Nawaz, Muhammad Faisal Manzoor, Noman Walayat, Claudia Terezia Socol, Cristina Maria Maerescu, Rana Muhammad Aadil

Abstract readReview
In one paragraph

Review in Frontiers in nutrition, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Khunsha ShakeelNational Institute of Food Science and Technology, University of Agriculture, Faisalabad, Pakistan.
Roshina RabailNational Institute of Food Science and Technology, University of Agriculture, Faisalabad, Pakistan.
Iahtisham-Ul-HaqKauser Abdulla Malik School of Life Sciences, Forman Christian College (A Chartered University), Lahore, Pakistan.
Sabrina SeharNational Institute of Food Science and Technology, University of Agriculture, Faisalabad, Pakistan.
Asad NawazShenzhen Key Laboratory of Marine Microbiome Engineering, Institute for Advanced Study, Shenzhen University, Shenzhen, China.
Muhammad Faisal ManzoorSchool of Food and Biological Engineering, Jiangsu University, Zhenjiang, China.
Noman WalayatCollege of Food Science and Technology, Zhejiang University of Technology, Hangzhou, China.
Claudia Terezia SocolDepartment of Genetics, University of Oradea, Oradea, Romania.
Cristina Maria MaerescuDepartment of Genetics, University of Oradea, Oradea, Romania.
Rana Muhammad AadilNational Institute of Food Science and Technology, University of Agriculture, Faisalabad, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Camel milk is known as the white gold of the desert because it contains within it a variety of nutrients which play a key role in the human diet. The health benefits of camel milk have been described for a variety of diseases such as diabetes, kidney disease, hepatitis, etc. including improved overall survival. A major health burden worldwide is liver diseases, and the ninth leading cause of death in Western countries is due to liver cirrhosis. Treatment is mostly ineffective for cirrhosis, fatty liver, and chronic hepatitis which are the most common diseases of the liver; furthermore current treatments carry the risk of side effects, and are often extremely expensive, particularly in the developing world. A systematic review of studies was performed to determine the association of consumption of camel milk on multiple diseases of the liver. The impact of camel milk on the laboratory tests related to the liver disorders, viral hepatitis, non-alcoholic fatty liver disease (NAFLD), cirrhosis, and hepatocellular carcinoma (HCC) were evaluated. The consumption of camel milk was accompanied by modulation of the values of serum gamma-glutamyl transferase, aspartate aminotransferase, and alanine aminotransferase in persons who are at risk of liver disease. In the patients with chronic liver disease, it was observed that they have low rates of mortality and low chances of progression to cirrhosis when they consume camel milk. Therefore, in patients with liver diseases, the addition of camel milk to their normal daily diet plan should be encouraged. In this review, camel milk's impact on the different kinds of liver diseases or any disorder associated with liver functioning was evaluated. Camel milk has a therapeutic as well as a preventive role in the maintenance and improving the metabolic regulations of the body.

Indexed as

camel milkcirrhosishepatitishepatocellular carcinomaliver disordersnon-alcoholic fatty liver disease

Identifiers

PMID36185679
PMCPMC9520982

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.